Methods for assessing tophus response during urate lowering therapy in treatment tophaceous gout
CA2766309A1
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
MX2011013488A
Methods for assessing tophus response during urate lowering therapy in treatment tophaceous gout.
US2007254029A1
Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1
WO2008051178A2
Purification of proteins with cationic surfactant
TW200722435A
Purification of proteins with cationic surfactant
SG161247A1
Variant forms of urate oxidase and use thereof
US2005266009A1
Antibodies and uses thereof
WO2004002528A1
Compositions and methods for therapeutic treatment
AU2003263764A1
Antibodies and uses thereof
BR0116764A
isolated molecules comprising epitopes containing sulfated moieties, antibodies to said epitopes and their uses
US7087722B1
Fibrin binding domain polypeptides and uses and methods of producing same
